Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;27:190-196

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walker, B. R.
Right arrow Articles by Edwards, C. R.W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walker, B. R.
Right arrow Articles by Edwards, C. R.W.

(Hypertension. 1996;27:190-196.)
© 1996 American Heart Association, Inc.


Articles

Increased Vasoconstrictor Sensitivity to Glucocorticoids in Essential Hypertension

Brian R. Walker; Ruth Best; Cedric H.L. Shackleton; Paul L. Padfield; Christopher R.W. Edwards

From the Department of Medicine, Western General Hospital, University of Edinburgh (Scotland, UK), and the Research Institute, Children's Hospital, Oakland, Calif (C.H.L.S.).

Abstract Glucocorticoids raise blood pressure but were thought not to play a pathophysiological role in essential hypertension when it was demonstrated that cortisol secretion rates and circulating concentrations are normal in this disease. However, recent observations suggest that increased tissue sensitivity to cortisol, mediated by either abnormal glucocorticoid receptors or impaired inactivation of cortisol by 11ß-dehydrogenase, may allow cortisol to raise blood pressure despite normal circulating concentrations. We studied 11 patients with essential hypertension and 11 matched normotensive control subjects. Dermal vasoconstriction after topical application of both cortisol (16±4 versus 32±5 U, control subjects versus hypertensive patients; P<.02) and beclomethasone dipropionate (75±10 versus 100±7 U; P<.05) was increased in the hypertensive patients. Hypothalamic-pituitary glucocorticoid receptor sensitivity was normal, as judged by basal cortisol secretion rates and suppression of plasma cortisol during sequential overnight dexamethasone suppression tests. 11ß-Dehydrogenase activity was impaired in essential hypertension, as judged by prolonged half-lives of [11{alpha}-3H]cortisol (44±4 versus 58±4 minutes, control subjects versus hypertensive patients; P<.02). However, this did not correlate with the dermal vasoconstrictor response. We conclude that vasoconstrictor sensitivity to glucocorticoids is increased in essential hypertension and that this may initiate and/or sustain the increased peripheral vascular resistance that characterizes this disease. The mechanism of increased sensitivity remains uncertain, but it will be important to establish whether it relates to genetic abnormalities of the glucocorticoid receptor that have been observed in animal models and young individuals who are predisposed to essential hypertension.


Key Words: glucocorticoids • hypertension, essential • skin • vasoconstriction • receptors, glucocorticoid • metabolism




This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
V. F. Panoulas, K. M. J. Douglas, A. Stavropoulos-Kalinoglou, G. S. Metsios, P. Nightingale, M. D. Kita, M. S. Elisaf, and G. D. Kitas
Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis
Rheumatology, January 1, 2008; 47(1): 72 - 75.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
B. R Walker
Glucocorticoids and Cardiovascular Disease
Eur. J. Endocrinol., November 1, 2007; 157(5): 545 - 559.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
V. F. Panoulas, K. M. J. Douglas, H. J. Milionis, A. Stavropoulos-Kalinglou, P. Nightingale, M. D. Kita, A. L. Tselios, G. S. Metsios, M. S. Elisaf, and G. D. Kitas
Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis
Rheumatology, September 1, 2007; 46(9): 1477 - 1482.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Chamarthi, N. S. Kolatkar, S. C. Hunt, J. S. Williams, E. W. Seely, N. J. Brown, L. J. Murphey, X. Jeunemaitre, and G. H. Williams
Urinary Free Cortisol: An Intermediate Phenotype and a Potential Genetic Marker for a Salt-Resistant Subset of Essential Hypertension
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1340 - 1346.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. G. Atanasov, I. D. Ignatova, L. G. Nashev, B. Dick, P. Ferrari, F. J. Frey, and A. Odermatt
Impaired Protein Stability of 11beta-Hydroxysteroid Dehydrogenase Type 2: A Novel Mechanism of Apparent Mineralocorticoid Excess
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1262 - 1270.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. G. Bechtold and D. A. Scheuer
Glucocorticoids act in the dorsal hindbrain to modulate baroreflex control of heart rate
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R1003 - R1011.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. S. Chriguer, L. L. K. Elias, I. M. da Silva Jr., J. G. H. Vieira, A. C. Moreira, and M. de Castro
Glucocorticoid Sensitivity in Young Healthy Individuals: in Vitro and in Vivo Studies
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5978 - 5984.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
L. A. Schachner, C. Lamerson, M. P. Sheehan, M. Boguniewicz, J. Mosser, S. Raimer, T. Shull, E. Jaracz, and for the US Tacrolimus Ointment Study Group
Tacrolimus Ointment 0.03% Is Safe and Effective for the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Patients: Results From a Randomized, Double-Blind, Vehicle-Controlled Study
Pediatrics, September 1, 2005; 116(3): e334 - e342.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. M. Gold, I. Dziobek, K. Rogers, A. Bayoumy, P. F. McHugh, and A. Convit
Hypertension and Hypothalamo-Pituitary-Adrenal Axis Hyperactivity Affect Frontal Lobe Integrity
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3262 - 3267.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. A. DeLano, R. Balete, and G. W. Schmid-Schonbein
Control of oxidative stress in microcirculation of spontaneously hypertensive rats
Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H805 - H812.
[Abstract] [Full Text] [PDF]


Home page
Recent Prog Horm ResHome page
J. R. Seckl, N. M. Morton, K. E. Chapman, and B. R. Walker
Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue
Recent Prog. Horm. Res., January 1, 2004; 59(1): 359 - 393.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. A. Scheuer, A. G. Bechtold, S. S. Shank, and S. F. Akana
Glucocorticoids act in the dorsal hindbrain to increase arterial pressure
Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H458 - H467.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. S. Shank and D. A. Scheuer
Glucocorticoids reduce responses to AMPA receptor activation and blockade in nucleus tractus solitarius
Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1751 - H1761.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. C. Andrews, O. Herlihy, D. E. W. Livingstone, R. Andrew, and B. R. Walker
Abnormal Cortisol Metabolism and Tissue Sensitivity to Cortisol in Patients with Glucose Intolerance
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5587 - 5593.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. A. Scheuer and A. G. Bechtold
Glucocorticoids modulate baroreflex control of heart rate in conscious normotensive rats
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R475 - R483.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. W.F. Hadoke, C. Christy, Y. V. Kotelevtsev, B. C. Williams, C. J. Kenyon, J. R. Seckl, J. J. Mullins, and B. R. Walker
Endothelial Cell Dysfunction in Mice After Transgenic Knockout of Type 2, but Not Type 1, 11{beta}-Hydroxysteroid Dehydrogenase
Circulation, December 4, 2001; 104(23): 2832 - 2837.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
L Patel, J K Wales, M S Kibirige, A A Massarano, J M Couriel, P E Clayton, and G. RUSSELL
Symptomatic adrenal insufficiency during inhaled corticosteroid treatment
Arch. Dis. Child., October 1, 2001; 85(4): 330 - 334.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. A. Scheuer and A. G. Bechtold
Glucocorticoids potentiate central actions of angiotensin to increase arterial pressure
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2001; 280(6): R1719 - R1726.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. A. Scheuer and S. W. Mifflin
Glucocorticoids modulate baroreflex control of renal sympathetic nerve activity
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1440 - R1449.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. A. Whitworth, G. J. Mangos, and J. J. Kelly
Cushing, Cortisol, and Cardiovascular Disease
Hypertension, November 1, 2000; 36(5): 912 - 916.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Ebrecht, A. Buske-Kirschbaum, D. Hellhammer, S. Kern, N. Rohleder, B. Walker, and C. Kirschbaum
Tissue Specificity of Glucocorticoid Sensitivity in Healthy Adults
J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3733 - 3739.
[Abstract] [Full Text]


Home page
HypertensionHome page
R. C. Y. Lin, W. Y. S. Wang, and B. J. Morris
Association and Linkage Analyses of Glucocorticoid Receptor Gene Markers in Essential Hypertension
Hypertension, December 1, 1999; 34(6): 1186 - 1192.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Takami, Z. Y. H. Wong, M. Stebbing, and S. B. Harrap
Linkage analysis of glucocorticoid and beta 2-adrenergic receptor genes with blood pressure and body mass index
Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1379 - H1384.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Christ and M. Wehling
Cardiovascular steroid actions: swift swallows or sluggish snails?
Cardiovasc Res, October 1, 1998; 40(1): 34 - 44.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Panarelli, C. D. Holloway, R. Fraser, J. M. C. Connell, M. C. Ingram, N. H. Anderson, and C. J. Kenyon
Glucocorticoid Receptor Polymorphism, Skin Vasoconstriction, and Other Metabolic Intermediate Phenotypes in Normal Human Subjects
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1846 - 1852.
[Abstract] [Full Text]


Home page
HypertensionHome page
B. R. Walker, D. I.W. Phillips, J. P. Noon, M. Panarelli, R. Andrew, H. V. Edwards, D. W. Holton, J. R. Seckl, D. J. Webb, and G. C. M. Watt
Increased Glucocorticoid Activity in Men With Cardiovascular Risk Factors
Hypertension, April 1, 1998; 31(4): 891 - 895.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. H.M. van Uum, A. R.M.M. Hermus, P. Smits, T. Thien, and J. W.M. Lenders
The role of 11{beta}-hydroxysteroid dehydrogenase in the pathogenesis of hypertension
Cardiovasc Res, April 1, 1998; 38(1): 16 - 24.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. I. W. Phillips, D. J. P. Barker, C. H. D. Fall, J. R. Seckl, C. B. Whorwood, P. J. Wood, and B. R. Walker
Elevated Plasma Cortisol Concentrations: A Link between Low Birth Weight and the Insulin Resistance Syndrome?
J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 757 - 760.
[Abstract] [Full Text]


Home page
HypertensionHome page
D. S. Gardner, A. A. Jackson, and S. C. Langley-Evans
Maintenance of Maternal Diet-Induced Hypertension in the Rat Is Dependent on Glucocorticoids
Hypertension, December 1, 1997; 30(6): 1525 - 1530.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
P. C. White, T. Mune, and A. K. Agarwal
11{beta}-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess
Endocr. Rev., February 1, 1997; 18(1): 135 - 156.
[Abstract] [Full Text]